BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25211518)

  • 1. Expression of intratumoral forkhead box protein 3 in posttransplant lymphoproliferative disorders: clinical features and survival outcomes.
    Berglund D; Kinch A; Edman E; Backlin C; Enblad G; Larsson E; Molin D; Pauksens K; Sundström C; Baecklund E
    Transplantation; 2015 May; 99(5):1036-42. PubMed ID: 25211518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 expression and survival in posttransplant lymphoproliferative disorders.
    Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
    Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased CD200 expression in post-transplant lymphoproliferative disorders correlates with an increased frequency of FoxP3(+) regulatory T cells.
    Vaughan JW; Shi M; Horna P; Olteanu H
    Ann Diagn Pathol; 2020 Oct; 48():151585. PubMed ID: 32829067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
    Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
    Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the posttransplant lymphoproliferative disorder subtype on survival.
    Koff JL; Li JX; Zhang X; Switchenko JM; Flowers CR; Waller EK
    Cancer; 2018 Jun; 124(11):2327-2336. PubMed ID: 29579330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-adapted Treatment for Severe B-Lineage Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation in Children.
    Giraldi E; Provenzi M; Conter V; Colledan M; Bolognini S; Foglia C; Sebastiani R; Fiocchi R; Gianatti A; DʼAntiga L; Rambaldi A
    Transplantation; 2016 Feb; 100(2):437-45. PubMed ID: 26270449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric evaluation of posttransplant B-cell lymphoproliferative disorders.
    Kaleem Z; Hassan A; Pathan MH; White G
    Arch Pathol Lab Med; 2004 Feb; 128(2):181-6. PubMed ID: 14736286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?
    Birkeland SA; Hamilton-Dutoit S
    Transplantation; 2003 Sep; 76(6):984-8. PubMed ID: 14508366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
    Cherikh WS; Kauffman HM; McBride MA; Maghirang J; Swinnen LJ; Hanto DW
    Transplantation; 2003 Nov; 76(9):1289-93. PubMed ID: 14627905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990-2009.
    Yoon SO; Yu E; Cho YM; Suh C; Kim KM; Han DJ; Lee SG; Huh J
    Clin Transplant; 2012; 26(1):67-73. PubMed ID: 21269330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.
    Kinch A; Cavelier L; Bengtsson M; Baecklund E; Enblad G; Backlin C; Thunberg U; Sundström C; Pauksens K
    Am J Transplant; 2014 Dec; 14(12):2838-45. PubMed ID: 25307322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR; Nalesnik MA; Swerdlow SH
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of early and late PTLD development in pediatric solid organ transplant recipients.
    Schober T; Framke T; Kreipe H; Schulz TF; Großhennig A; Hussein K; Baumann U; Pape L; Schubert S; Wingen AM; Jack T; Koch A; Klein C; Maecker-Kolhoff B
    Transplantation; 2013 Jan; 95(1):240-6. PubMed ID: 23222898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
    Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
    J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral expression of FoxP3-positive regulatory T-cells in T-cell lymphoma: no correlation with survival.
    Lundberg J; Berglund D; Molin D; Kinch A
    Ups J Med Sci; 2019 Apr; 124(2):105-110. PubMed ID: 30856039
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow findings of 23 Korean post-transplant lymphoproliferative disorder patients: a single-center experience.
    Cho MC; Park CJ; Huh J; Chi HS; Jang S; Suh C; Lee KH; Lee JH; Seo JJ; Im HJ
    Clin Transplant; 2012; 26(4):E381-7. PubMed ID: 22694766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous lymphoproliferative disorders in organ transplant recipients: update 2014.
    Seçkin D
    G Ital Dermatol Venereol; 2014 Aug; 149(4):401-8. PubMed ID: 25068227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion.
    Vakiani E; Nandula SV; Subramaniyam S; Keller CE; Alobeid B; Murty VV; Bhagat G
    Hum Pathol; 2007 Feb; 38(2):315-25. PubMed ID: 17134734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.